Company intelligence / Profile preview

Dalian Zhongxin Medicine

Ownership: Private
Development stage: Other

Overview

Dalian Zhongxin Medicine is a Chinese pharmaceutical manufacturer primarily engaged in the production and sale of generic small molecule drugs. The company has been involved in legal disputes over patent infringement related to levornidazole, indicating activity in anti-infective or antibiotic markets. No clinical-stage innovative drug development was identified; operations focus on commercialized generics.

Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Dalian Zhongxin Medicine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dalian Zhongxin Medicine.

Explore the full profile